http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 11 Sep 2026 02:57:42 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR280+at+Berenberg/27050045.html Berenberg analyst Harry Gillis raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR280.00 (from EUR270.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR280+at+Berenberg/27050045.html Fri, 11 Sep 2026 02:57:42 -0400 SARTF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR280+at+Berenberg/27050045.html Berenberg analyst Harry Gillis raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR280.00 (from EUR270.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR280+at+Berenberg/27050045.html Fri, 11 Sep 2026 02:57:42 -0400 SARTF http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR280+at+Berenberg/27050045.html Berenberg analyst Harry Gillis raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR280.00 (from EUR270.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR280+at+Berenberg/27050045.html Fri, 11 Sep 2026 02:57:42 -0400 SARTF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR280+at+Berenberg/27050045.html Berenberg analyst Harry Gillis raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR280.00 (from EUR270.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR280+at+Berenberg/27050045.html Fri, 11 Sep 2026 02:57:42 -0400 SARTF http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR300+at+Barclays/27032456.html Barclays analyst Charles Pitman raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR300.00 (from EUR260.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR300+at+Barclays/27032456.html Tue, 08 Sep 2026 05:39:28 -0400 SARTF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR300+at+Barclays/27032456.html Barclays analyst Charles Pitman raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR300.00 (from EUR260.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR300+at+Barclays/27032456.html Tue, 08 Sep 2026 05:39:28 -0400 SARTF http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR300+at+Barclays/27032456.html Barclays analyst Charles Pitman raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR300.00 (from EUR260.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR300+at+Barclays/27032456.html Tue, 08 Sep 2026 05:39:28 -0400 SARTF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR300+at+Barclays/27032456.html Barclays analyst Charles Pitman raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR300.00 (from EUR260.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR300+at+Barclays/27032456.html Tue, 08 Sep 2026 05:39:28 -0400 SARTF http://www.streetinsider.com/Intl+Ratings/BofA+Securities+Reiterates+Buy+Rating+on+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29/27027332.html <p>BofA Securities reiterated a Buy rating and EUR280.00 price target on Sartorius AG (SRT3:GR) (OTC: SARTF).</p> http://www.streetinsider.com/Intl+Ratings/BofA+Securities+Reiterates+Buy+Rating+on+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29/27027332.html Fri, 04 Sep 2026 06:07:08 -0400 SARTF http://www.streetinsider.com/Intl+Ratings/BofA+Securities+Reiterates+Buy+Rating+on+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29/27027332.html <p>BofA Securities reiterated a Buy rating and EUR280.00 price target on Sartorius AG (SRT3:GR) (OTC: SARTF).</p> http://www.streetinsider.com/Intl+Ratings/BofA+Securities+Reiterates+Buy+Rating+on+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29/27027332.html Fri, 04 Sep 2026 06:07:08 -0400 SARTF http://www.streetinsider.com/Intl+Ratings/UBS+Upgrades+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+to+Buy/26951883.html <p>UBS analyst Matthew Weston upgraded Sartorius AG (SRT3:GR) (OTC: SARTF) from Neutral to Buy with a price target of EUR300.00 (from EUR240.00).</p><p>The analyst comments: “Sartorius is well-positioned for accelerating growth from 2027-2029E. We see strong underlying demand in bioprocess consumables, driven by increased pharmaceutical use with aging population, the high proportion of biologic assets in biopharma R&D pipelines and the likely uplift in production volumes from blockbuster biosimilar launches 2028-2032E. In addition, the onshoring of US biomanufacturing should drive a bolus of Bioprocess equipment demand from 2H27E. With accelerating underlying growth drivers we see significant potential for stock outperformance. We http://www.streetinsider.com/Intl+Ratings/UBS+Upgrades+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+to+Buy/26951883.html Thu, 20 Aug 2026 02:48:26 -0400 SARTF http://www.streetinsider.com/Upgrades/UBS+Upgrades+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+to+Buy/26951883.html <p>UBS analyst Matthew Weston upgraded Sartorius AG (SRT3:GR) (OTC: SARTF) from Neutral to Buy with a price target of EUR300.00 (from EUR240.00).</p><p>The analyst comments: “Sartorius is well-positioned for accelerating growth from 2027-2029E. We see strong underlying demand in bioprocess consumables, driven by increased pharmaceutical use with aging population, the high proportion of biologic assets in biopharma R&D pipelines and the likely uplift in production volumes from blockbuster biosimilar launches 2028-2032E. In addition, the onshoring of US biomanufacturing should drive a bolus of Bioprocess equipment demand from 2H27E. With accelerating underlying growth drivers we see significant potential for stock outperformance. We http://www.streetinsider.com/Upgrades/UBS+Upgrades+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+to+Buy/26951883.html Thu, 20 Aug 2026 02:48:26 -0400 SARTF http://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+to+Buy/26951883.html <p>UBS analyst Matthew Weston upgraded Sartorius AG (SRT3:GR) (OTC: SARTF) from Neutral to Buy with a price target of EUR300.00 (from EUR240.00).</p><p>The analyst comments: “Sartorius is well-positioned for accelerating growth from 2027-2029E. We see strong underlying demand in bioprocess consumables, driven by increased pharmaceutical use with aging population, the high proportion of biologic assets in biopharma R&D pipelines and the likely uplift in production volumes from blockbuster biosimilar launches 2028-2032E. In addition, the onshoring of US biomanufacturing should drive a bolus of Bioprocess equipment demand from 2H27E. With accelerating underlying growth drivers we see significant potential for stock outperformance. We http://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+to+Buy/26951883.html Thu, 20 Aug 2026 02:48:26 -0400 SARTF http://www.streetinsider.com/Intl+Ratings/UBS+Upgrades+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+to+Buy/26951883.html <p>UBS analyst Matthew Weston upgraded Sartorius AG (SRT3:GR) (OTC: SARTF) from Neutral to Buy with a price target of EUR300.00 (from EUR240.00).</p><p>The analyst comments: “Sartorius is well-positioned for accelerating growth from 2027-2029E. We see strong underlying demand in bioprocess consumables, driven by increased pharmaceutical use with aging population, the high proportion of biologic assets in biopharma R&D pipelines and the likely uplift in production volumes from blockbuster biosimilar launches 2028-2032E. In addition, the onshoring of US biomanufacturing should drive a bolus of Bioprocess equipment demand from 2H27E. With accelerating underlying growth drivers we see significant potential for stock outperformance. We http://www.streetinsider.com/Intl+Ratings/UBS+Upgrades+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+to+Buy/26951883.html Thu, 20 Aug 2026 02:48:26 -0400 SARTF http://www.streetinsider.com/Upgrades/UBS+Upgrades+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+to+Buy/26951883.html <p>UBS analyst Matthew Weston upgraded Sartorius AG (SRT3:GR) (OTC: SARTF) from Neutral to Buy with a price target of EUR300.00 (from EUR240.00).</p><p>The analyst comments: “Sartorius is well-positioned for accelerating growth from 2027-2029E. We see strong underlying demand in bioprocess consumables, driven by increased pharmaceutical use with aging population, the high proportion of biologic assets in biopharma R&D pipelines and the likely uplift in production volumes from blockbuster biosimilar launches 2028-2032E. In addition, the onshoring of US biomanufacturing should drive a bolus of Bioprocess equipment demand from 2H27E. With accelerating underlying growth drivers we see significant potential for stock outperformance. We http://www.streetinsider.com/Upgrades/UBS+Upgrades+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+to+Buy/26951883.html Thu, 20 Aug 2026 02:48:26 -0400 SARTF http://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+to+Buy/26951883.html <p>UBS analyst Matthew Weston upgraded Sartorius AG (SRT3:GR) (OTC: SARTF) from Neutral to Buy with a price target of EUR300.00 (from EUR240.00).</p><p>The analyst comments: “Sartorius is well-positioned for accelerating growth from 2027-2029E. We see strong underlying demand in bioprocess consumables, driven by increased pharmaceutical use with aging population, the high proportion of biologic assets in biopharma R&D pipelines and the likely uplift in production volumes from blockbuster biosimilar launches 2028-2032E. In addition, the onshoring of US biomanufacturing should drive a bolus of Bioprocess equipment demand from 2H27E. With accelerating underlying growth drivers we see significant potential for stock outperformance. We http://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+to+Buy/26951883.html Thu, 20 Aug 2026 02:48:26 -0400 SARTF http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Lowered+to+EUR260+at+Barclays/26815145.html Barclays analyst Charles Pitman lowered the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR260.00 (from EUR270.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Lowered+to+EUR260+at+Barclays/26815145.html Mon, 27 Jul 2026 04:43:32 -0400 SARTF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Lowered+to+EUR260+at+Barclays/26815145.html Barclays analyst Charles Pitman lowered the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR260.00 (from EUR270.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Lowered+to+EUR260+at+Barclays/26815145.html Mon, 27 Jul 2026 04:43:32 -0400 SARTF http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Lowered+to+EUR260+at+Barclays/26815145.html Barclays analyst Charles Pitman lowered the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR260.00 (from EUR270.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Lowered+to+EUR260+at+Barclays/26815145.html Mon, 27 Jul 2026 04:43:32 -0400 SARTF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Lowered+to+EUR260+at+Barclays/26815145.html Barclays analyst Charles Pitman lowered the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR260.00 (from EUR270.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Lowered+to+EUR260+at+Barclays/26815145.html Mon, 27 Jul 2026 04:43:32 -0400 SARTF http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR270+at+Berenberg/26754631.html Berenberg analyst Harry Gillis raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR270.00 (from EUR250.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR270+at+Berenberg/26754631.html Fri, 10 Jul 2026 05:50:25 -0400 SARTF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR270+at+Berenberg/26754631.html Berenberg analyst Harry Gillis raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR270.00 (from EUR250.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR270+at+Berenberg/26754631.html Fri, 10 Jul 2026 05:50:25 -0400 SARTF http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR270+at+Berenberg/26754631.html Berenberg analyst Harry Gillis raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR270.00 (from EUR250.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR270+at+Berenberg/26754631.html Fri, 10 Jul 2026 05:50:25 -0400 SARTF http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR270+at+Berenberg/26754631.html Berenberg analyst Harry Gillis raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR270.00 (from EUR250.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR270+at+Berenberg/26754631.html Fri, 10 Jul 2026 05:50:25 -0400 SARTF http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR300+at+HSBC/26594520.html HSBC analyst Shubhangi Gupta raised the price target on Sartorius AG (SRT3:GR) (OTC: SARTF) to EUR300.00 (from EUR263.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Sartorius+AG+%28SRT3%3AGR%29+%28SARTF%29+PT+Raised+to+EUR300+at+HSBC/26594520.html Wed, 03 Jun 2026 05:13:08 -0400 SARTF